Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 8,052,540,000
  • Market Capitalization, $K 8,052,540
  • Shares Outstanding, K 77,250
  • 36-Month Beta 1.30
  • Price/Book N/A
  • Price/Earnings ttm 21.79
  • Annual Dividend & Yield 0.31 (0.30%)
  • Most Recent Dividend 0.032 on 09/26/18
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
100.66 +4.36%
on 10/29/18
114.86 -8.54%
on 10/17/18
-9.70 (-8.45%)
since 10/16/18
3-Month
100.66 +4.36%
on 10/29/18
122.97 -14.57%
on 10/01/18
-11.22 (-9.65%)
since 08/16/18
52-Week
100.22 +4.82%
on 04/06/18
122.97 -14.57%
on 10/01/18
+1.45 (+1.40%)
since 11/16/17

Most Recent Stories

More News
Biotech ETFs in Focus on String of Q3 Earnings Beat

Biotech ETFs draw attention post impressive Q3 results.

IBB : 105.05 (+0.86%)
BBH : 120.06 (+1.07%)
FBT : 135.46 (+1.18%)
GILD : 69.20 (-0.83%)
AMGN : 194.18 (+0.90%)
ALXN : 118.62 (-0.89%)
BIIB : 324.05 (+0.72%)
Biotech ETFs in Focus on String of Q3 Earnings Beat

Biotech ETFs draw attention post impressive Q3 results.

IBB : 105.05 (+0.86%)
BBH : 120.06 (+1.07%)
FBT : 135.46 (+1.18%)
GILD : 69.20 (-0.83%)
AMGN : 194.18 (+0.90%)
ALXN : 118.62 (-0.89%)
BIIB : 324.05 (+0.72%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 51.14 (+1.23%)
IBB : 105.05 (+0.86%)
VRTX : 165.11 (-0.94%)
REGN : 345.33 (+1.08%)
AMGN : 194.18 (+0.90%)
XBI : 79.52 (+2.54%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 51.14 (+1.23%)
ILMN : 319.93 (+0.13%)
IBB : 105.05 (+0.86%)
VRTX : 165.11 (-0.94%)
AMGN : 194.18 (+0.90%)
XBI : 79.52 (+2.54%)
Health Care ETFs Outperforming: Will the Rally Last?

Health care ETFs are defensive ones, which helped those to shine amid market doldrums.

XLU : 54.88 (+1.54%)
XPH : 43.39 (+0.37%)
XLV : 92.04 (+1.01%)
XLY : 106.37 (-0.39%)
IBB : 105.05 (+0.86%)
IHI : 211.35 (+1.30%)
XLP : 56.06 (+0.25%)
Health Care ETFs Outperforming: Will the Rally Last?

Health care ETFs are defensive ones, which helped those to shine amid market doldrums.

XLU : 54.88 (+1.54%)
XPH : 43.39 (+0.37%)
XLV : 92.04 (+1.01%)
XLY : 106.37 (-0.39%)
IBB : 105.05 (+0.86%)
IHI : 211.35 (+1.30%)
XLP : 56.06 (+0.25%)
Biotech ETFs in Focus on String of Q2 Earnings Beat

Biotech ETFs draw attention post impressive Q2 results.

IBB : 105.05 (+0.86%)
FBT : 135.46 (+1.18%)
BBH : 120.06 (+1.07%)
IEIH : 24.28 (-1.58%)
GILD : 69.20 (-0.83%)
AMGN : 194.18 (+0.90%)
ALXN : 118.62 (-0.89%)
BIIB : 324.05 (+0.72%)
Biotech ETFs in Focus on String of Q2 Earnings Beat

Biotech ETFs draw attention post impressive Q2 results.

IBB : 105.05 (+0.86%)
FBT : 135.46 (+1.18%)
BBH : 120.06 (+1.07%)
IEIH : 24.28 (-1.58%)
GILD : 69.20 (-0.83%)
AMGN : 194.18 (+0.90%)
ALXN : 118.62 (-0.89%)
BIIB : 324.05 (+0.72%)
Should You Invest in the PowerShares Dynamic Biotechnology & Genome Portfolio (PBE)?

Sector ETF report for PBE

PBE : 51.14 (+1.23%)
ILMN : 319.93 (+0.13%)
IBB : 105.05 (+0.86%)
QGEN : 34.60 (+0.26%)
XBI : 79.52 (+2.54%)
BIIB : 324.05 (+0.72%)
Why These Small Cap Biotech ETFs are Soaring

These biotech ETFs have surged this year thanks mainly to tax reform, rising M&A and positive regulatory backdrop.

BBC : 27.17 (+3.07%)
CNCR : 20.97 (+1.30%)
IBB : 105.05 (+0.86%)
PSCH : 125.09 (+1.35%)
XBI : 79.52 (+2.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade IBB with:

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 106.89
1st Resistance Point 105.97
Last Price 105.05
1st Support Level 103.71
2nd Support Level 102.37

See More

52-Week High 122.97
Fibonacci 61.8% 114.28
Fibonacci 50% 111.60
Fibonacci 38.2% 108.91
Last Price 105.05
52-Week Low 100.22

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar